As of the end of October, there have been in excess of 50,000 vaginal mesh lawsuits filed against manufacturers of these devices – yet a recent study published in the British Medical Journal suggests that this treatment for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) is generally regarded as safe. Earlier this year, at a meeting of the American Urological Association, it was announced that the connection between the mesh and the painful symptoms suffered by these women was “unclear.” Nonetheless, the number of revision surgeries to remove the mesh is increasing.
At the same time, testimony in a recent vaginal mesh lawsuit was excluded from the trial – leading the jury to side with the defendant. The witness, the plaintiff's surgeon, stated that had he known that the material used for the mesh was not intended for “permanent implantation” in a human body, he would not have used the product on his patient.
One thing is patently obvious: the use of transvaginal meshes (TVMs) is quicker and more cost-effective for profit-driven hospitals than safer, proven treatments (such as using a patient's own tissues). Implanting a TVM through the vagina can be accomplished in as little as 15 minutes, and healing time from the procedure is greatly reduced – meaning lower costs for the hospital.
TVM's have been recalled in every other country in the world – but not the USA, where, the Affordable Care Act notwithstanding, health and medical services continue to be for-profit commodities. Given this fact, as well as the corporatist leanings of a significant number of American legislators and judges, the outcome of this vaginal mesh lawsuit should not have come as a surprise.
For More Information Regarding the Transvaginal Mesh Litigation, visit our Vaginal Mesh Lawsuit Page.